The apparent inability of elevated atrial-natriuretic peptide (ANP) levels to cause natriuresis and diuresis in children with heart failure may be related to a reduced response of target organs to ANP. The cellular effects of ANP seem to be mediated by cCMP a s the second messenger of ANP. Simultaneous measuremen of ANP and cGMP has been shown to be a useful tool to study the cellular response to ANP. Therefore, plasma ANP and cGMP levels were measured by radioimmonoassay in 168 healthy childrer and in 47 children with congenital cardiac diseases. In healthy children ANP and cGMP plasma levels were measured in the range of 5-109 pglml (mean 45.5) and 0.2-2.8 pmollml (mean 1.3) respectively. In children with cardiac diseases significantly higher ANP (range 30-980, mean 280 pglml) and cGMP levels (range 0.2-6.0, mean 2.8 pmollml) were determined. There was a highly significant correlation between the two in children with cardiac diseases (p<0.001). Furthermore, a significant correlation was found between right atrial pressure and ANP levels (p<0.01) suggesting that atrial stretch is a stimulus for ANP release. The positive correlation between ANP and cCMP levels disagrees with the hypothesis that the cellular response to ANP is diminished in children with cardiac diseases.
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In conclusion : IGF-I i s present in the r a t pancreas and in the medium of i s l e t s c e l l s in culture together with a binding protein. Effect of GH on IGF-I production in the medium seems t o indicate t h a t GH multiplicatory a c t i v i t y on O-cell might be mediated through local IGF-I stimulation.
